Transaction in Own Shares

Summary by AI BETAClose X

CVS Group plc has announced the purchase of 7,816 ordinary shares on December 30, 2025, as part of its ongoing share buyback program. The shares were acquired from Joh. Berenberg, Gossler & Co. KG at prices ranging from 1,266.00 pence to 1,284.00 pence, with a volume-weighted average price of 1,278.10 pence. These shares are intended for cancellation, which will reduce the total number of issued ordinary shares to 70,711,273. Since the commencement of the buyback program, CVS has repurchased a total of 1,029,510 ordinary shares at a weighted average price of 1,221.04 pence.

Disclaimer*

CVS Group plc
31 December 2025
 

31 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 30 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

30/12/2025

Aggregate number of Ordinary Shares purchased:

7,816

Lowest price paid per share (GBp):

1,266.00

Highest price paid per share (GBp):

1,284.00

Volume weighted average price paid per share (GBp):

1,278.10


CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,711,273 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,711,273 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 1,029,510 Ordinary Shares in aggregate at a weighted average price of 1,221.04 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 


305

1274

30/12/2025 08:09:00

1361359287617626

XLON


107

1272

30/12/2025 08:21:40

1361359287618151

XLON


68

1268

30/12/2025 09:05:23

1361359287620071

XLON


80

1268

30/12/2025 09:18:28

1361359287620422

XLON


197

1266

30/12/2025 11:03:19

1361359287624152

XLON


8

1268

30/12/2025 11:29:41

1361359287625079

XLON


16

1268

30/12/2025 11:29:41

1361359287625080

XLON


56

1268

30/12/2025 11:29:41

1361359287625081

XLON


6

1268

30/12/2025 11:29:41

1361359287625082

XLON


110

1272

30/12/2025 11:43:36

1361359287625435

XLON


6

1272

30/12/2025 11:43:36

1361359287625436

XLON


320

1272

30/12/2025 11:43:36

1361359287625434

XLON


146

1272

30/12/2025 11:43:36

1361359287625437

XLON


36

1272

30/12/2025 11:43:36

1361359287625438

XLON


12

1272

30/12/2025 11:43:36

1361359287625439

XLON


16

1272

30/12/2025 11:43:36

1361359287625440

XLON


4

1272

30/12/2025 11:43:36

1361359287625441

XLON


1

1272

30/12/2025 11:43:36

1361359287625442

XLON


2

1272

30/12/2025 11:43:36

1361359287625443

XLON


1

1272

30/12/2025 11:43:36

1361359287625444

XLON


4

1272

30/12/2025 11:43:36

1361359287625445

XLON


1

1272

30/12/2025 11:43:36

1361359287625446

XLON


3

1272

30/12/2025 11:43:36

1361359287625447

XLON


2

1272

30/12/2025 11:43:36

1361359287625448

XLON


1

1272

30/12/2025 11:43:36

1361359287625449

XLON


146

1272

30/12/2025 11:43:36

1361359287625450

XLON


36

1272

30/12/2025 11:43:45

1361359287625465

XLON


125

1272

30/12/2025 11:43:51

1361359287625484

XLON


2

1272

30/12/2025 11:57:01

1361359287625951

XLON


68

1274

30/12/2025 12:02:03

1361359287626110

XLON


6

1274

30/12/2025 12:08:15

1361359287626304

XLON


6

1274

30/12/2025 12:08:15

1361359287626305

XLON


62

1276

30/12/2025 12:57:19

1361359287627763

XLON


68

1278

30/12/2025 12:59:07

1361359287627832

XLON


70

1276

30/12/2025 13:05:01

1361359287628057

XLON


217

1276

30/12/2025 13:05:01

1361359287628058

XLON


189

1276

30/12/2025 13:05:03

1361359287628066

XLON


374

1278

30/12/2025 13:38:31

1361359287629420

XLON


160

1278

30/12/2025 13:38:31

1361359287629421

XLON


15

1276

30/12/2025 13:40:00

1361359287629515

XLON


108

1276

30/12/2025 13:43:35

1361359287629635

XLON


200

1280

30/12/2025 13:46:03

1361359287629770

XLON


68

1280

30/12/2025 14:00:44

1361359287630123

XLON


68

1284

30/12/2025 14:30:08

1361359287631556

XLON


155

1284

30/12/2025 14:31:00

1361359287631729

XLON


371

1284

30/12/2025 14:31:00

1361359287631730

XLON


61

1282

30/12/2025 14:35:12

1361359287632600

XLON


62

1282

30/12/2025 14:35:12

1361359287632601

XLON


123

1282

30/12/2025 14:35:12

1361359287632602

XLON


55

1282

30/12/2025 14:35:12

1361359287632603

XLON


225

1282

30/12/2025 14:35:12

1361359287632604

XLON


115

1280

30/12/2025 14:51:28

1361359287634654

XLON


92

1280

30/12/2025 14:51:29

1361359287634655

XLON


230

1284

30/12/2025 14:59:35

1361359287635272

XLON


294

1284

30/12/2025 14:59:35

1361359287635273

XLON


329

1280

30/12/2025 15:06:01

1361359287635916

XLON


195

1280

30/12/2025 15:06:01

1361359287635917

XLON


11

1280

30/12/2025 15:34:56

1361359287638557

XLON


35

1280

30/12/2025 15:34:56

1361359287638558

XLON


1

1280

30/12/2025 15:34:56

1361359287638559

XLON


3

1280

30/12/2025 15:34:56

1361359287638560

XLON


12

1280

30/12/2025 15:34:56

1361359287638561

XLON


5

1280

30/12/2025 15:34:56

1361359287638562

XLON


1

1280

30/12/2025 15:34:56

1361359287638563

XLON


79

1280

30/12/2025 15:34:56

1361359287638564

XLON


17

1280

30/12/2025 15:34:56

1361359287638565

XLON


6

1280

30/12/2025 15:34:56

1361359287638566

XLON


30

1280

30/12/2025 15:34:56

1361359287638567

XLON


96

1280

30/12/2025 15:43:42

1361359287639483

XLON


35

1280

30/12/2025 15:43:42

1361359287639484

XLON


32

1280

30/12/2025 15:43:42

1361359287639485

XLON


70

1280

30/12/2025 15:43:42

1361359287639486

XLON


291

1280

30/12/2025 15:43:43

1361359287639487

XLON


59

1280

30/12/2025 15:45:03

1361359287639688

XLON


95

1280

30/12/2025 15:45:03

1361359287639689

XLON


75

1280

30/12/2025 15:45:03

1361359287639690

XLON


218

1280

30/12/2025 15:45:04

1361359287639691

XLON


197

1280

30/12/2025 16:09:15

1361359287642278

XLON


111

1280

30/12/2025 16:09:15

1361359287642279

XLON


5

1280

30/12/2025 16:26:34

1361359287644298

XLON


149

1280

30/12/2025 16:26:34

1361359287644299

XLON


67

1280

30/12/2025 16:26:34

1361359287644300

XLON


95

1280

30/12/2025 16:26:34

1361359287644302

XLON


96

1280

30/12/2025 16:28:22

1361359287644546

XLON


16

1280

30/12/2025 16:28:22

1361359287644547

XLON


106

1280

30/12/2025 16:28:24

1361359287644548

XLON


 

 

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                  +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker)                                                                                                                              +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)                                                                                                                            cvsg@camarco.co.uk

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings